Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title:Acknowledgements to Reviewers
Volume: 16 Issue: 3
Author(s):
Affiliation:
Export Options
About this article
Cite this article as:
, Acknowledgements to Reviewers, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2017; 16 (3) . https://dx.doi.org/10.2174/187152301603180330102343
DOI https://dx.doi.org/10.2174/187152301603180330102343 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
17
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Engineering Approaches to Develop the Next Generation of Antibodies to Respiratory Targets
Inflammation & Allergy - Drug Targets (Discontinued) Mast Cell Cytokine and Chemokine Responses to Bacterial and Viral Infection
Current Pharmaceutical Design Analysis of Trends and Opportunities of Anti-Allergy Patents in China from 1998 to 2008
Recent Patents on Inflammation & Allergy Drug Discovery The Role of Eosinophils in Non-Parasitic Infections
Endocrine, Metabolic & Immune Disorders - Drug Targets Progress in Developing Amphiphilic Cyclodextrin-Based Nanodevices for Drug Delivery
Current Topics in Medicinal Chemistry Review of Erectile Dysfunction in Diabetic Animal Models
Current Diabetes Reviews Fatty Acids - Induced Lipotoxicity and Inflammation
Current Drug Metabolism Patent Selections
Recent Patents on Anti-Infective Drug Discovery The Yin and Yang of Non-Neuronal α7-Nicotinic Receptors in Inflammation and Autoimmunity
Current Drug Targets Direct Covalent Modification as a Strategy to Inhibit Nuclear Factor-Kappa B
Current Medicinal Chemistry Glycyrrhetinic Acid Ammonium Loaded Microspheres Using Colocasia esculenta and Bombax ceiba mucilages: In Vitro and In Vivo Characterization
Current Drug Therapy Failure of Immune Homeostasis - The Consequences of Under and Over Reactivity
Current Drug Targets - Immune, Endocrine & Metabolic Disorders New Approaches to Target Cancer Stem Cells: Current Scenario
Mini-Reviews in Medicinal Chemistry Multi-walled Carbon Nanotubes Reinforced into Hollow Fiber by Chitosan Sol-gel for Solid/Liquid Phase Microextraction of NSAIDs from Urine Prior to HPLC-DAD Analysis
Current Pharmaceutical Biotechnology Melanoma Immunotherapy: Past, Present, and Future
Current Pharmaceutical Design Mechanisms of Neural Stem Cell Fate Determination: Extracellular Cues and Intracellular Programs
Current Stem Cell Research & Therapy Therapeutic Use of Heparin beyond Anticoagulation
Current Drug Discovery Technologies Second Generation Abl Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone
Recent Patents on Anti-Cancer Drug Discovery Homocysteine Enhances Transmigration of Rat Monocytes through a Brain Capillary Endothelial Cell Monolayer via ICAM-1
Current Neurovascular Research Modifying Toll-like Receptor 9 Signaling for Therapeutic Use
Mini-Reviews in Medicinal Chemistry